BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8851592)

  • 1. Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa.
    Cappelletty DM; Rybak MJ
    Antimicrob Agents Chemother; 1996 Mar; 40(3):677-83. PubMed ID: 8851592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
    Lyon MD; Smith KR; Saag MS; Cloud GA; Cobbs CG
    Antimicrob Agents Chemother; 1986 Jul; 30(1):25-30. PubMed ID: 3092731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro interaction of piperacillin and imipenem/cilastatin combined with aminoglycosides against Pseudomonas aeruginosa].
    Yamashiro Y; Ogake N; Takahata M; Minami S
    Jpn J Antibiot; 2000 Apr; 53(4):194-200. PubMed ID: 10868299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
    Chen YH; Peng CF; Lu PL; Tsai JJ; Chen TP
    Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations.
    Chow AW; Wong J; Bartlett KH; Shafran SD; Stiver HG
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1368-72. PubMed ID: 2508546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro susceptibility of Pseudomonas aeruginosa to old and new beta-lactam antibiotics and aminoglycosides.
    Van der Auwera P; Schuyteneer F
    J Antimicrob Chemother; 1983 Jun; 11(6):511-5. PubMed ID: 6411673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multidrug-resistant Pseudomonas aeruginosa.
    Meyer RD; Liu S
    Diagn Microbiol Infect Dis; 1988 Nov; 11(3):151-7. PubMed ID: 3149927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activity of aminoglycoside-beta-lactam combinations against Pseudomonas aeruginosa with an unusual aminoglycoside antibiogram.
    Clark RB; Pakiz CB; Hostetter MK
    Med Microbiol Immunol; 1990; 179(2):77-86. PubMed ID: 2113159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling.
    Yadav R; Bulitta JB; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Scribner RK; Marks MI; Weber AH; Tarpay MM; Welch DF
    Antimicrob Agents Chemother; 1982 Jun; 21(6):939-43. PubMed ID: 6810757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity and synergy of ureido penicillins and aminoglycosides against Pseudomonas aeruginosa.
    Hoogkamp-Korstanje JA; Westerdaal NA
    Infection; 1982; 10 Suppl 3():S257-61. PubMed ID: 6818158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
    Staneck JL; Glenn S; DiPersio JR; Leist PA
    J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of aminoglycosides and cephalosporins against Pseudomonas aeruginosa. Correlation between interaction index and killing curve.
    Perea EJ; Clavijo E; Nogales MC; García Luque IG
    J Antimicrob Chemother; 1988 Aug; 22(2):175-83. PubMed ID: 3141342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of bactericidal activity of selected beta-lactam antimicrobials against Pseudomonas aeruginosa.
    Smith JA; Henry DA
    J Antimicrob Chemother; 1988 Dec; 22(6):849-55. PubMed ID: 3149632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic activities of combinations of beta-lactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa.
    Takahashi K; Kanno H
    Antimicrob Agents Chemother; 1984 Nov; 26(5):789-91. PubMed ID: 6440482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of multidrug-resistant Pseudomonas aeruginosa isolated from drinking water and hospitalized patients in Jordan.
    Tarazi YH; Abu-Basha E; Ismail ZB; Al-Jawasreh SI
    Acta Trop; 2021 May; 217():105859. PubMed ID: 33582141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of various antibiotic combinations using the E-Test method in multiresistant Pseudomonas aeruginosa strains.
    Kocazeybek B; Arabaci U; Erentürk S; Akdur H
    Chemotherapy; 2002 Mar; 48(1):31-5. PubMed ID: 11901254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of ceftazidime, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
    Rolston KV; Chandrasekar PH; LeFrock JL; Schell RF
    Chemotherapy; 1984; 30(1):31-4. PubMed ID: 6420119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro combination effects of astromicin and beta-lactam antibiotics against Pseudomonas aeruginosa. In vitro synergistic activities].
    Iyama Y; Sato K; Okachi R
    Jpn J Antibiot; 1985 Apr; 38(4):1022-8. PubMed ID: 3928940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy with cefsulodin or piperacillin and three aminoglycosides or aztreonam against aminoglycoside resistant strains of Pseudomonas aeruginosa.
    Baltch AL; Bassey C; Hammer MC; Smith RP; Conroy JV; Michelsen PB
    J Antimicrob Chemother; 1991 Jun; 27(6):801-8. PubMed ID: 1938686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.